Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor Agonist
By Lori Solomon HealthDay Reporter
TUESDAY, May 14, 2024 -- One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, according to the results of a new KFF Health Tracking Poll, released May 10.
Alex Montero, from KFF Health, and colleagues analyzed data collected April 23 to May 1, 2024, online and by telephone, among a nationally representative sample of 1,479 U.S. adults in English and Spanish.
Survey results show that of the adults who report ever using GLP-1 RAs, 43 percent do so for diabetes, 25 percent for heart disease, and 22 percent for overweight or obesity. By race, Black and Hispanic adults report higher use than White adults (18, 13, and 10 percent, respectively). Most users say they took the drug to treat a chronic condition, including diabetes or heart disease (62 percent), while four in 10 say they took it primarily to lose weight. More than half of users (54 percent) say it was difficult to afford the cost, including 22 percent who say it was "very difficult." Even among insured adult users, 53 percent report the cost was difficult to afford.
"About eight in ten (79 percent) adults who have taken GLP-1 drugs report getting these drugs or a prescription for them from their primary care doctor or a specialist, while fewer report getting them from an online provider or website (11 percent), a medical spa or aesthetic medical center (10 percent), or from somewhere else (2 percent)," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Small Differences in Weight Change With First-Line Antidepressants
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...
American Diabetes Association, June 21-24
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world...
Few With Type 2 Diabetes Receive Guideline-Recommended CKD Screening
MONDAY, July 1, 2024 -- Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.